XORTX Therapeutics Inc. SEC filings XRTX

XORTX Therapeutics Inc. has 291 filings in SEC EDGAR's recent list, going back to Jan 25, 2018. Its latest annual report, Form 20-F, was filed on Mar 20, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Oct 8, 2026. The company's fiscal year ends on December 31.

XORTX Therapeutics Inc. SEC filings
Form Description Filed Period
6-K Current report (foreign issuer) Oct 8, 2026 Oct 8, 2026
6-K Current report (foreign issuer) Sep 18, 2026 Sep 18, 2026
6-K Current report (foreign issuer) Sep 10, 2026 Sep 10, 2026
6-K Current report (foreign issuer) Sep 9, 2026 Sep 9, 2026
6-K Current report (foreign issuer) Sep 4, 2026 Sep 4, 2026
6-K Current report (foreign issuer) Aug 28, 2026 Aug 28, 2026
6-K Current report (foreign issuer) Aug 17, 2026 Jun 30, 2026
6-K Current report (foreign issuer) Aug 4, 2026 Jul 31, 2026
6-K Current report (foreign issuer) Jul 29, 2026 Jul 29, 2026
6-K Current report (foreign issuer) Jun 15, 2026 Jun 15, 2026
6-K Current report (foreign issuer) Jun 12, 2026 Jun 12, 2026
6-K Current report (foreign issuer) May 19, 2026 May 19, 2026
6-K Current report (foreign issuer) May 19, 2026 Mar 31, 2026
424B4 Prospectus May 15, 2026 —
6-K Current report (foreign issuer) May 14, 2026 May 14, 2026
EFFECT Filing May 13, 2026 —
6-K Current report (foreign issuer) May 8, 2026 May 8, 2026
POS AM Filing May 8, 2026 —
POS AM Filing Apr 23, 2026 —
POS AM Filing Apr 22, 2026 —
6-K Current report (foreign issuer) Apr 21, 2026 Apr 21, 2026
6-K Current report (foreign issuer) Apr 16, 2026 Apr 13, 2026
6-K Current report (foreign issuer) Apr 1, 2026 Apr 1, 2026
6-K Current report (foreign issuer) Mar 27, 2026 Mar 26, 2026
6-K Current report (foreign issuer) Mar 27, 2026 Mar 26, 2026
6-K Current report (foreign issuer) Mar 27, 2026 Mar 26, 2026
6-K Current report (foreign issuer) Mar 26, 2026 Mar 25, 2026
6-K Current report (foreign issuer) Mar 24, 2026 Mar 24, 2026
20-F Annual report (foreign issuer) Mar 20, 2026 Dec 31, 2025
6-K Current report (foreign issuer) Mar 19, 2026 Mar 18, 2026
6-K Current report (foreign issuer) Mar 13, 2026 Mar 13, 2026
6-K Current report (foreign issuer) Mar 5, 2026 Mar 5, 2026
6-K Current report (foreign issuer) Mar 3, 2026 Mar 3, 2026
6-K Current report (foreign issuer) Feb 27, 2026 Dec 31, 2025
EFFECT Filing Feb 17, 2026 —
F-1/A Filing Feb 13, 2026 —
CORRESP Letter to the SEC Feb 12, 2026 —
6-K Current report (foreign issuer) Feb 5, 2026 Feb 4, 2026
6-K Current report (foreign issuer) Jan 2, 2026 Dec 31, 2025
6-K Current report (foreign issuer) Nov 17, 2025 Sep 30, 2025
6-K Current report (foreign issuer) Oct 31, 2025 Oct 31, 2025
6-K Current report (foreign issuer) Oct 29, 2025 Oct 29, 2025
SCHEDULE 13G Ownership over 5% (passive) Oct 27, 2025 —
6-K Current report (foreign issuer) Oct 23, 2025 Oct 22, 2025
424B5 Prospectus supplement Oct 23, 2025 —
6-K Current report (foreign issuer) Oct 21, 2025 Oct 20, 2025
6-K Current report (foreign issuer) Oct 21, 2025 Oct 21, 2025
6-K Current report (foreign issuer) Oct 21, 2025 Oct 20, 2025
6-K Current report (foreign issuer) Oct 17, 2025 Oct 17, 2025
6-K Current report (foreign issuer) Oct 17, 2025 Oct 17, 2025
F-1 Registration statement (foreign issuer) Sep 25, 2025 —
6-K Current report (foreign issuer) Sep 4, 2025 Sep 4, 2025
6-K Current report (foreign issuer) Sep 3, 2025 Sep 3, 2025
6-K Current report (foreign issuer) Aug 15, 2025 Jun 30, 2025
6-K Current report (foreign issuer) Aug 7, 2025 Aug 7, 2025
UPLOAD Letter from the SEC Aug 5, 2025 —
DRS Filing Jul 30, 2025 —
6-K Current report (foreign issuer) Jun 26, 2025 Jun 26, 2025
6-K Current report (foreign issuer) May 19, 2025 May 19, 2025
6-K Current report (foreign issuer) May 16, 2025 Mar 31, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2025 —
20-F Annual report (foreign issuer) May 12, 2025 Dec 31, 2024
NT 20-F Filing May 1, 2025 Dec 31, 2024
6-K Current report (foreign issuer) Apr 30, 2025 Apr 30, 2025
6-K Current report (foreign issuer) Apr 28, 2025 Apr 28, 2025
6-K Current report (foreign issuer) Apr 18, 2025 Apr 17, 2025
6-K Current report (foreign issuer) Apr 1, 2025 Mar 31, 2025
6-K Current report (foreign issuer) Mar 26, 2025 Dec 31, 2024
6-K Current report (foreign issuer) Mar 19, 2025 Mar 19, 2025
6-K Current report (foreign issuer) Feb 24, 2025 Feb 24, 2025
SCHEDULE 13G Ownership over 5% (passive) Feb 14, 2025 —
6-K Current report (foreign issuer) Jan 29, 2025 Jan 29, 2025
6-K Current report (foreign issuer) Jan 22, 2025 Jan 21, 2025
6-K Current report (foreign issuer) Jan 21, 2025 Jan 17, 2025
6-K Current report (foreign issuer) Jan 6, 2025 Jan 6, 2025
6-K Current report (foreign issuer) Dec 19, 2024 Dec 19, 2024
424B5 Prospectus supplement Dec 13, 2024 —
6-K Current report (foreign issuer) Dec 12, 2024 Dec 12, 2024
EFFECT Filing Nov 25, 2024 —
424B3 Prospectus Nov 22, 2024 —
424B3 Prospectus Nov 22, 2024 —
CORRESP Letter to the SEC Nov 22, 2024 —
UPLOAD Letter from the SEC Nov 20, 2024 —
F-1 Registration statement (foreign issuer) Nov 15, 2024 —
6-K Current report (foreign issuer) Nov 15, 2024 Sep 30, 2024
D Filing Oct 31, 2024 —
6-K Current report (foreign issuer) Oct 24, 2024 Oct 24, 2024
6-K Current report (foreign issuer) Oct 18, 2024 Oct 18, 2024
6-K Current report (foreign issuer) Oct 18, 2024 Oct 18, 2024
6-K Current report (foreign issuer) Oct 18, 2024 Oct 17, 2024
424B5 Prospectus supplement Oct 18, 2024 —
6-K Current report (foreign issuer) Oct 17, 2024 Oct 17, 2024
424B5 Prospectus supplement Oct 17, 2024 —
6-K Current report (foreign issuer) Oct 9, 2024 Oct 9, 2024
424B3 Prospectus Sep 24, 2024 —
424B3 Prospectus Sep 24, 2024 —
424B3 Prospectus Sep 24, 2024 —
424B3 Prospectus Sep 24, 2024 —
424B3 Prospectus Sep 24, 2024 —
424B3 Prospectus Sep 24, 2024 —
6-K Current report (foreign issuer) Sep 13, 2024 Sep 12, 2024
6-K Current report (foreign issuer) Sep 13, 2024 Sep 13, 2024
6-K Current report (foreign issuer) Sep 13, 2024 Sep 13, 2024
6-K/A Form 6-k/a Sep 13, 2024 Jun 30, 2024
6-K/A Form 6-k/a Sep 13, 2024 Dec 31, 2023
6-K Current report (foreign issuer) Sep 6, 2024 Sep 6, 2024
6-K Current report (foreign issuer) Sep 4, 2024 Sep 3, 2024
6-K Current report (foreign issuer) Aug 29, 2024 Aug 29, 2024
6-K Current report (foreign issuer) Aug 23, 2024 Aug 23, 2024
6-K Current report (foreign issuer) Aug 22, 2024 Sep 12, 2024
6-K Current report (foreign issuer) Aug 20, 2024 Aug 20, 2024
6-K Current report (foreign issuer) Aug 15, 2024 Jun 30, 2024
424B3 Prospectus Jul 12, 2024 —
424B3 Prospectus Jul 12, 2024 —
6-K Current report (foreign issuer) Jul 1, 2024 Jun 28, 2024
424B3 Prospectus Jun 13, 2024 —
424B3 Prospectus Jun 13, 2024 —
424B3 Prospectus Jun 13, 2024 —
424B3 Prospectus Jun 13, 2024 —
424B3 Prospectus Jun 13, 2024 —
424B3 Prospectus Jun 13, 2024 —
424B3 Prospectus Jun 13, 2024 —
424B3 Prospectus Jun 13, 2024 —
424B3 Prospectus Jun 13, 2024 —
424B3 Prospectus Jun 13, 2024 —
424B3 Prospectus Jun 13, 2024 —
424B3 Prospectus Jun 13, 2024 —
6-K Current report (foreign issuer) Jun 12, 2024 Mar 11, 2024
6-K Current report (foreign issuer) Jun 4, 2024 Jun 4, 2024
6-K Current report (foreign issuer) May 20, 2024 May 17, 2024
6-K Current report (foreign issuer) May 17, 2024 Mar 31, 2024
20-F Annual report (foreign issuer) May 10, 2024 Dec 31, 2023
NT 20-F Filing May 1, 2024 Dec 31, 2023
6-K Current report (foreign issuer) Apr 30, 2024 Apr 30, 2024
6-K Current report (foreign issuer) Apr 22, 2024 Apr 22, 2024
6-K Current report (foreign issuer) Apr 8, 2024 Apr 8, 2024
6-K Current report (foreign issuer) Apr 8, 2024 Apr 8, 2024
6-K Current report (foreign issuer) Apr 4, 2024 Dec 31, 2023
6-K Current report (foreign issuer) Mar 27, 2024 Mar 27, 2024
6-K Current report (foreign issuer) Mar 20, 2024 Mar 19, 2024
SC 13G/A Amended ownership over 5% (passive) Feb 14, 2024 —
6-K Current report (foreign issuer) Jan 3, 2024 Jan 3, 2024
6-K Current report (foreign issuer) Jan 2, 2024 Jan 2, 2024
6-K Current report (foreign issuer) Nov 30, 2023 Nov 30, 2023
6-K Current report (foreign issuer) Nov 30, 2023 Nov 30, 2023
424B5 Prospectus supplement Nov 30, 2023 —
6-K Current report (foreign issuer) Nov 29, 2023 Nov 29, 2023
6-K Current report (foreign issuer) Nov 16, 2023 Sep 30, 2023
6-K Current report (foreign issuer) Nov 13, 2023 Nov 10, 2023
6-K Current report (foreign issuer) Nov 8, 2023 Nov 8, 2023
6-K Current report (foreign issuer) Nov 2, 2023 Nov 2, 2023
6-K Current report (foreign issuer) Oct 30, 2023 Oct 27, 2023
6-K Current report (foreign issuer) Oct 30, 2023 Oct 27, 2023
6-K Current report (foreign issuer) Oct 25, 2023 Oct 25, 2023
6-K Current report (foreign issuer) Oct 25, 2023 Oct 25, 2023
6-K Current report (foreign issuer) Oct 12, 2023 Oct 12, 2023
6-K Current report (foreign issuer) Oct 4, 2023 Oct 4, 2023
6-K Current report (foreign issuer) Oct 4, 2023 Oct 25, 2023
6-K Current report (foreign issuer) Sep 28, 2023 Sep 28, 2023
6-K Current report (foreign issuer) Sep 12, 2023 Sep 11, 2023
6-K Current report (foreign issuer) Sep 7, 2023 Sep 7, 2023
6-K Current report (foreign issuer) Aug 29, 2023 Aug 29, 2023
424B3 Prospectus Aug 25, 2023 —
424B3 Prospectus Aug 25, 2023 —
6-K Current report (foreign issuer) Aug 15, 2023 Jun 30, 2023
424B3 Prospectus Aug 14, 2023 —
424B3 Prospectus Aug 14, 2023 —
EFFECT Filing Aug 7, 2023 —
EFFECT Filing Aug 7, 2023 —
6-K Current report (foreign issuer) Aug 4, 2023 Aug 4, 2023
POS AM Filing Aug 4, 2023 —
POS AM Filing Aug 4, 2023 —
6-K Current report (foreign issuer) Jun 30, 2023 Jun 29, 2023
6-K Current report (foreign issuer) Jun 29, 2023 Jun 29, 2023
6-K Current report (foreign issuer) Jun 27, 2023 Jun 23, 2023
6-K Current report (foreign issuer) Jun 6, 2023 Jun 6, 2023
6-K Current report (foreign issuer) May 30, 2023 Jun 28, 2023
6-K Current report (foreign issuer) May 24, 2023 May 24, 2023
6-K Current report (foreign issuer) May 16, 2023 Mar 31, 2023
6-K Current report (foreign issuer) May 4, 2023 May 4, 2023
20-F Annual report (foreign issuer) Apr 28, 2023 Dec 31, 2022
6-K Current report (foreign issuer) Apr 3, 2023 Dec 31, 2022
6-K Current report (foreign issuer) Mar 14, 2023 Mar 14, 2023
SC 13G Ownership over 5% (passive) Feb 14, 2023 —
6-K Current report (foreign issuer) Feb 7, 2023 Feb 7, 2023
EFFECT Filing Feb 3, 2023 —
CORRESP Letter to the SEC Feb 1, 2023 —
6-K Current report (foreign issuer) Feb 1, 2023 Feb 1, 2023
UPLOAD Letter from the SEC Jan 31, 2023 —
F-3 Shelf registration (foreign issuer) Jan 27, 2023 —
20-F/A Amended annual report (foreign issuer) Jan 27, 2023 Dec 31, 2021
6-K Current report (foreign issuer) Jan 19, 2023 Jan 19, 2023
6-K Current report (foreign issuer) Jan 3, 2023 Jan 3, 2023
6-K Current report (foreign issuer) Dec 19, 2022 Dec 19, 2022
6-K Current report (foreign issuer) Dec 8, 2022 Dec 8, 2022
6-K Current report (foreign issuer) Nov 28, 2022 Nov 28, 2022
6-K Current report (foreign issuer) Nov 28, 2022 Nov 25, 2022
6-K Current report (foreign issuer) Nov 16, 2022 Nov 16, 2022
424B3 Prospectus Nov 14, 2022 —
6-K Current report (foreign issuer) Nov 14, 2022 Sep 30, 2022

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
XRTX (Nasdaq)
Fiscal year ends
December 31
Incorporated in
British Columbia, Canada
Headquarters
Vancouver, British Columbia, Canada
SEC filer status
Non-accelerated filer, Emerging growth company
SEC CIK
1729214

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.